# Louisville Reproductive Center – FDA Inspection, Aug 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/f6d2adbc-dd73-4aba-b108-a45d69750d8d
Source feed: FDA_Inspections

> FDA inspection 1215469 of Louisville Reproductive Center, August 22, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 1271. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215469
- Company Name: Louisville Reproductive Center
- Inspection Date: 2023-08-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1268429 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/98c29722-5505-4871-93d3-0e802fff7729)
- FDA Inspection 1172027 - 2022-06-14
- [FDA Inspection 1139891 - 2021-04-08](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/be4e0020-85d0-4a7c-9d95-c5c1e7d28a6a)
- FDA Inspection 1037302 - 2018-01-04
- [FDA Inspection 1014448 - 2017-06-15](https://www.keypedia.com/records/fda_inspections/louisville-reproductive-center/f22a3592-b4fd-42f3-b583-f2f9734fab50)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/louisville-reproductive-center/b1b4afdf-389d-463a-9b58-d06525fee135

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
